proxitane ag sanitiser
solvay interox pty. ltd. - hydrogen peroxide; acetic acid; peroxyacetic acid - aqueous concentrate - hydrogen peroxide ungrouped active 282.0 g/l; acetic acid acid-general active 85.0 g/l; peroxyacetic acid acid-general active 56.0 g/l - disinfectant - food processing and/or preserving plant | pharmaceutical plant | processing and manufacturing plants - bacteria | bacterial spore | fungal spore | fungus | fungal leaf spots | fungi | fungus diseases | leaf spot diseases | leaf spots
teveten tablets 300 mg
solvay pharma inc - eprosartan (eprosartan mesylate) - tablet - 300mg - eprosartan (eprosartan mesylate) 300mg - angiotensin ii receptor antagonists
marinol cap 10mg capsule
solvay pharma inc - dronabinol - capsule - 10mg - dronabinol 10mg - miscellaneous antiemetics
serc 8 mg tablet
solvay pharma inc - betahistine hydrochloride - tablet - 8mg - betahistine hydrochloride 8mg - miscellaneous therapeutic agents
teveten tablet 600 mg
abbott laboratories (singapore ) private limited - eprosartan (as eprosartan mesylate) - tablet, film coated - 600 mg - eprosartan (as eprosartan mesylate) 600 mg
proxitane ahc disinfectant
solvay interox pty. ltd. - hydrogen peroxide; peroxyacetic acid - aqueous concentrate - hydrogen peroxide ungrouped active 282.0 g/l; peroxyacetic acid acid-general active 56.0 g/l - disinfectant - animal housing | cattery | cracks and/or crevices | dairy or milking shed | egg emersion | floor | general disinfection (walls, - bacteria | fungus | general disinfection | mould | protozoa | spore | virus | antiviral agent | aviaries | catteries | detergent | feeding utensils | flesh wounds | floor | fungal leaf spots | fungi | fungus diseases | germicidal detergent | kennel | leaf spot diseases | leaf spots | mastitis | mould growth | poultry cages | protozoans | stables | toilets (not septic) | walls
budeprion xl xl- bupropion hydrochloride tablet, film coated, extended release
ncs healthcare of ky, inc dba vangard labs - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 150 mg - major depressive disorder: bupropion hydrochloride extended-release tablets (xl) are indicated for the treatment of major depressive disorder. the efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled trials of inpatients and in one 6-week controlled trial of outpatients whose diagnoses corresponded most closely to the major depression category of the apa diagnostic and statistical manual (dsm) (see clinical trials). a major depressive episode (dsm-iv) implies the presence of 1) depressed mood or 2) loss of interest or pleasure; in addition, at least 5 of the following symptoms have been present during the same 2-week period and represent a change from previous functioning: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration,
teveten
pharmacy retailing (nz) ltd t/a healthcare logistics - eprosartan mesilate 200mg - film coated tablet - 200 mg - active: eprosartan mesilate 200mg excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry pregelatinised maize starch purified water
teveten
pharmacy retailing (nz) ltd t/a healthcare logistics - eprosartan mesilate 300mg - film coated tablet - 300 mg - active: eprosartan mesilate 300mg excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry white oy-s-9603 pregelatinised maize starch purified water
zumenon 1mg tablets
sigma pharmaceuticals plc - estradiol - oral tablet - 1mg